Topics

Articles

Properly supporting market access for a newly launched product with a single indication is challenging. Doing so for multiple indications, or supporting subsequent indications, can have a compounding effect on the degree of difficulty for getting everything right. 

Strategizing High-Wire, Multi-Indication Launches

Analysis explores where drug prices are derived from, and whether a holistic societal approach can help determine these products’ true value. 

How Are High Drug Prices Justified?

Cohort study explores value-based insurance designs, while also determining how one’s place of residency can potentially play a role. 

Can Lower Out-of-Pocket Costs Help Improve Diabetes Patients’ Short-Term Health?

Technavio analysis notes that an increase drug patent expirations could be a contributing factor. 

Forecast Predicts Generic Drug Market Will Grow Upwards of $175B Over the Next Three Years

Cohort study dives into whether low income subsidy losses are associated with disability status, age, and race and ethnicity. 

Exploring the Frequency That Beneficiaries Encounter Subsidy Losses Attributed to Medicare Part D’s Low-Income Subsidy Program

Pharma Commerce travels to Orlando for a pulse-check on this fast-evolving landscape in patient care.  

Access Insights and Information Abound

And the need to boost awareness of this critical healthcare resource.

A Look at the Medicare 'Extra Help' Program

An analysis of the two main new models for pharmacy—unique direct—to-consumer for brands and cash pay for generics—and what members of industry think about them.

Who Moved My Prescription? Part II

An analysis conducted by RAND Corporation determines that majority of new Rx medications are first sold in the United States before making their debut in other countries. 

A Comparison of Prescription Drug Availability 

A dive into this market reveals that the latest numbers yield promising results—a global value of a worldwide $1.6 trillion—but it will continue to be attributed to past, present, and future healthcare spending. 

Market Access and Pricing